Jose Ignacio
Rodríguez Barbosa
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (9)
2023
2022
-
Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
Scientific Reports, Vol. 12, Núm. 1
-
Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance
Frontiers in Immunology, Vol. 13
-
The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection
Translational Research, Vol. 239, pp. 103-123
2020
-
The role of TNFR2 and DR3 in the in vivo expansion of tregs in t cell depleting transplantation regimens
International Journal of Molecular Sciences, Vol. 21, Núm. 9
2019
-
HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT
Cellular and Molecular Immunology, Vol. 16, Núm. 7, pp. 679-682
2015
-
Human bone marrow stromal cells differentiate into corneal tissue and prevent ocular graft-versus-host disease in mice
Cell Transplantation, Vol. 24, Núm. 12, pp. 2423-2433
2013
-
LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation
American Journal of Transplantation, Vol. 13, Núm. 3, pp. 541-551
2011
-
B-and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity
Transplantation, Vol. 92, Núm. 10, pp. 1085-1093